ReviewCurrent oncology reports2020

Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development.

Leandro Jonata Carvalho Oliveira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.